DE FERRARI, LAURA
 Distribuzione geografica
Continente #
EU - Europa 1.828
AS - Asia 231
NA - Nord America 82
SA - Sud America 21
OC - Oceania 1
Totale 2.163
Nazione #
IT - Italia 1.796
SG - Singapore 88
US - Stati Uniti d'America 79
CN - Cina 74
VN - Vietnam 51
BR - Brasile 13
FR - Francia 12
AR - Argentina 5
DE - Germania 5
BD - Bangladesh 4
FI - Finlandia 4
HK - Hong Kong 4
GB - Regno Unito 3
CA - Canada 2
ID - Indonesia 2
IQ - Iraq 2
NL - Olanda 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PY - Paraguay 1
RU - Federazione Russa 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.163
Città #
Genova 963
Genoa 565
Vado Ligure 136
Rapallo 127
Singapore 39
San Jose 33
Ashburn 23
Beijing 16
Ho Chi Minh City 13
Lauterbourg 12
Hanoi 11
Council Bluffs 4
Helsinki 4
Hong Kong 4
Santa Clara 4
Haiphong 3
São Paulo 3
Amsterdam 2
Biên Hòa 2
Can Tho 2
Cardiff 2
Da Nang 2
Dhaka 2
Frankfurt am Main 2
New York 2
Asunción 1
Baghdad 1
Bangkok 1
Birmingham 1
Bình Dương 1
Des Moines 1
Egg Harbor Township 1
Essen 1
Florence 1
Formosa 1
Islamabad 1
Istanbul 1
Jakarta 1
Jundiaí 1
Karbala 1
Khimki 1
Kyiv 1
Lanús 1
Las Balsas 1
Lomas de Zamora 1
Long Xuyen 1
Maceió 1
Melbourne 1
Mexico City 1
Milan 1
Montreal 1
Munich 1
Muscat 1
Niederuzwil 1
Ninh Bình 1
Nuremberg 1
Ourinhos 1
Pato Branco 1
Paulínia 1
Phú Thọ 1
Piscataway 1
Pomigliano d'Arco 1
Quận Ba 1
Samarkand 1
San Fernando 1
San Juan 1
Santiago 1
Shanghai 1
Suzhou 1
São Luís de Montes Belos 1
São Pedro da Aldeia 1
Tianjin 1
Tokyo 1
Toronto 1
Tramandaí 1
Tubarão 1
Viamão 1
Warsaw 1
Whittier 1
Woodbridge 1
Zagreb 1
Totale 2.032
Nome #
Galectin-3: An early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months 204
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 195
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 172
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 168
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 166
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients. 162
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. 159
Molecular diagnosis and precision medicine in allergy management 152
Salbutamol: how does it enter smooth muscle cells? 148
Correlated avalanches in TES noise power spectra 141
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life 120
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders 100
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 87
Plasma Galectin-3 and urine proteomics predict FEV1 improvement in omalizumab-treated patients with severe allergic asthma: Results from the PROXIMA sub-study 65
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps 58
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy 53
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 51
Totale 2.201
Categoria #
all - tutte 6.979
article - articoli 6.979
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 15 15 12
2021/2022151 5 2 22 16 1 15 13 38 8 11 7 13
2022/2023152 14 15 1 10 19 23 2 11 27 3 25 2
2023/2024105 13 17 2 15 12 17 11 1 7 0 3 7
2024/2025369 11 18 15 22 33 46 20 84 16 16 47 41
2025/2026588 107 24 49 60 110 30 82 24 55 47 0 0
Totale 2.201